Pages that link to "Q44741231"

The following pages link to Curcumin-induced apoptosis in scleroderma lung fibroblasts: role of protein kinase cepsilon. (Q44741231):

Displaying 26 items.

• Curcumin modulates the inflammatory response and inhibits subsequent fibrosis in a mouse model of viral-induced acute respiratory distress syndrome (Q28486257) (← links)
• nPKCepsilon, a P2Y2-R downstream effector in regulated mucin secretion from airway goblet cells (Q28595001) (← links)
• Analysis of the Antiproliferative Effects of Curcumin and Nanocurcumin in MDA-MB231 as a Breast Cancer Cell Line (Q28830199) (← links)
• Curcumin activates the p38MPAK-HSP25 pathway in vitro but fails to attenuate diabetic nephropathy in DBA2J mice despite urinary clearance documented by HPLC (Q33745769) (← links)
• Circulating progenitor cells and scleroderma (Q33989134) (← links)
• Curcumin selectively induces apoptosis in cutaneous T-cell lymphoma cell lines and patients' PBMCs: potential role for STAT-3 and NF-kappaB signaling (Q34110250) (← links)
• Curcumin: a potential candidate in prevention of cancer via modulation of molecular pathways (Q34252516) (← links)
• Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases (Q34594807) (← links)
• Apoptosis modulation as a promising target for treatment of systemic sclerosis (Q35207610) (← links)
• Analysis of bronchoalveolar lavage fluid proteome from systemic sclerosis patients with or without functional, clinical and radiological signs of lung fibrosis. (Q35630007) (← links)
• Regulation of the expression of cyclooxygenases and production of prostaglandin I₂ and E₂ in human coronary artery endothelial cells by curcumin (Q36414995) (← links)
• "Spicing up" of the immune system by curcumin (Q36702820) (← links)
• The antioxidant response element and oxidative stress modifiers in airway diseases (Q37239760) (← links)
• Curcumin-induced fibroblast apoptosis and in vitro wound contraction are regulated by antioxidants and heme oxygenase: implications for scar formation. (Q37294693) (← links)
• Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? (Q37378063) (← links)
• Pharmacogenomic Characterization and Isobologram Analysis of the Combination of Ascorbic Acid and Curcumin-Two Main Metabolites of Curcuma longa-in Cancer Cells. (Q37620415) (← links)
• Emerging role of nanocarriers to increase the solubility and bioavailability of curcumin (Q38042744) (← links)
• Curcumin in inflammatory diseases (Q38071037) (← links)
• Curcumin and inflammatory bowel disease: potential and limits of innovative treatments. (Q38292885) (← links)
• Effects of curcumin on bleomycin-induced apoptosis in human malignant testicular germ cells. (Q39273288) (← links)
• Antifibrotic effects of curcumin are associated with overexpression of cathepsins K and L in bleomycin treated mice and human fibroblasts. (Q40468440) (← links)
• Expression of Ser729 phosphorylated PKCepsilon in experimental crescentic glomerulonephritis: an immunohistochemical study. (Q42722108) (← links)
• Combining time-resolved fluorescence with synchronous fluorescence spectroscopy to study bovine serum albumin-curcumin complex during unfolding and refolding processes (Q46298715) (← links)
• Low heme oxygenase-1 levels in patients with systemic sclerosis are associated with an altered Toll-like receptor response: another role for CXCL4? (Q50499077) (← links)
• Effect of curcumin on liposome: curcumin as a molecular probe for monitoring interaction of ionic liquids with 1,2-dipalmitoyl-sn-glycero-3-phosphocholine liposome (Q51466744) (← links)
• Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis. (Q64940918) (← links)